These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23050314)

  • 21. Novel composite fatty acid vesicles-in-Pluronic lecithin organogels for enhanced magnolol delivery in skin cancer treatment.
    Atef B; Ishak RAH; Badawy SS; Osman R
    Eur J Pharm Biopharm; 2024 Aug; 201():114379. PubMed ID: 38908488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.
    Sallam MA; Motawaa AM; Mortada SM
    Drug Dev Ind Pharm; 2015 Jan; 41(1):141-7. PubMed ID: 24171693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
    Lehman PA; Raney SG
    Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ; Sumanasekera W; Le UM
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluronic lecithin organogel (PLO) of diltiazem hydrochloride: effect of solvents/penetration enhancers on ex vivo permeation.
    Parhi R; Suresh P; Pattnaik S
    Drug Deliv Transl Res; 2016 Jun; 6(3):243-53. PubMed ID: 26754742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J; Addo RT
    Int J Pharm Compd; 2014; 18(4):348-50. PubMed ID: 25474865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of pluronic lecithin organogel containing fluocinolone acetonide.
    Patel D; Patel V
    Drug Dev Ind Pharm; 2021 Mar; 47(3):377-384. PubMed ID: 33493079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aceclofenac organogels: in vitro and in vivo characterization.
    Shaikh IM; Jadhav SL; Jadhav KR; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2009 Jan; 6(1):1-7. PubMed ID: 19418950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs.
    Krotscheck U; Boothe DM; Boothe HW
    Vet Ther; 2004; 5(3):202-11. PubMed ID: 15578452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
    Richards H; Thomas CP; Bowen JL; Heard CM
    J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and Evaluation of Pluronic Lecithin Organogels in Cosmetics.
    Jun Yang S; Yoon KS
    J Cosmet Sci; 2021; 72(3):325-346. PubMed ID: 35361319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, characterization, and in vitro release of new transdermal methimazole as alternative to oral delivery.
    Morales ME; Clarés B; López-Viota M; Ruiz MA
    Drug Deliv; 2009 Jan; 16(1):1-10. PubMed ID: 19555302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of lecithin organogel for topical delivery of fluconazole.
    Jadhav KR; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2009 Apr; 6(2):174-83. PubMed ID: 19450224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application.
    Esposito E; Drechsler M; Nastruzzi C; Cortesi R
    Curr Pharm Des; 2016; 22(35):5382-5399. PubMed ID: 27839503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
    Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
    Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal timolol delivery from a Pluronic gel.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2006 Nov; 116(2):e53-5. PubMed ID: 17718968
    [No Abstract]   [Full Text] [Related]  

  • 37. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
    Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
    Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organogels in drug delivery.
    Murdan S
    Expert Opin Drug Deliv; 2005 May; 2(3):489-505. PubMed ID: 16296770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin.
    Alsaab H; Alzhrani RM; Boddu SH
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1258-66. PubMed ID: 26599694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles.
    Ruiz MA; Clares B; Morales ME; Gallardo V
    Pharm Dev Technol; 2007; 12(6):637-44. PubMed ID: 18161637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.